Statements (9)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:affiliatedWith |
L01X Other antineoplastic agents
|
| gptkbp:assignee |
gptkb:WHO_Collaborating_Centre_for_Drug_Statistics_Methodology
|
| gptkbp:ATCCode |
gptkb:pembrolizumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
L01XE08
|
| gptkbp:part_of |
gptkb:ATC_Classification_System
|
| gptkbp:used_in |
oncology
|
| gptkbp:bfsParent |
gptkb:Tasigna
|
| gptkbp:bfsLayer |
5
|